Efficacy of low dose pirfenidone in idiopathic pulmonary fibrosis: Real world experiencefrom a tertiary university hospital
S. Kim (Seoul, Republic of Korea), J. Shin (Seoul, Republic of Korea), M. Song (Seoul, Republic of Korea), M. Park (Seoul, Republic of Korea), Y. Kang (Seoul, Republic of Korea)
Source: Virtual Congress 2020 – Real life in the field of idiopathic pulmonary fibrosis: treatments and registries

Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
S. Kim (Seoul, Republic of Korea), J. Shin (Seoul, Republic of Korea), M. Song (Seoul, Republic of Korea), M. Park (Seoul, Republic of Korea), Y. Kang (Seoul, Republic of Korea). Efficacy of low dose pirfenidone in idiopathic pulmonary fibrosis: Real world experiencefrom a tertiary university hospital. 1848
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you: